Related Experiment Video
Updated: Jan 27, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
31.2K
Do comprehensive medication review completion rates predict medication use and management quality?
Ying Wang1, Joel F Farley2, Stefanie P Ferreri3
1Independent Consultant, Ashland, MA, 01721, USA.
Research in Social & Administrative Pharmacy : RSAP
|March 29, 2019
Summary
Medicare Part D Comprehensive Medication Review (CMR) completion rates increased, but showed limited association with medication use quality measures. An unintended outcome was increased antipsychotic use in nursing home residents.
Area of Science:
- Health Services Research
- Pharmaceutical Policy
- Geriatric Pharmacy
Background:
- Medicare Part D Comprehensive Medication Review (CMR) is intended to improve medication use and management.
- Little is known about the impact of CMR completion rates on medication use and management related (MUMR) quality measures.
Purpose of the Study:
- To examine changes in Medicare Part D CMR completion rates over time.
- To assess the association between CMR completion rates and MUMR quality measures.
Main Methods:
- Longitudinal data analysis of Medicare Part D plan Star Rating and contract information.
- Statistical methods including t-tests, ANOVA, fixed-effects, and ordinary least squares models were used.
- Generalized Estimating Equations verified regression-adjusted associations.
Main Results:
- CMR completion rates significantly increased from 2013-2016, particularly in Medicare Advantage Prescription Drug Plans.
- Prior year CMR completion showed marginal positive effects on medication adherence (statins) and chronic disease management (COPD, beta blockers).
- Increased CMR completion was linked to higher chronic antipsychotic use in elderly nursing home residents, indicating a potential quality issue.
Conclusions:
- Plan-level CMR completion rates demonstrated limited and inconsistent associations with other MUMR measures.
- Findings suggest potential policy implications for the CMS Star Ratings program, quality bonus payments, and quality improvement initiatives for Medicare Part D plans.
Related Concept Videos
01:18Endocarditis III: Medical Management
237
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
237
01:14Myocarditis III: Medical Management
202
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
202
01:17Pericarditis III: Medical Management
344
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
344
01:30Heart Failure V: Medical Management
258
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
258
01:26Nephrotic Syndrome II : Assessment and Medical Management
235
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
235
01:25Mitral Regurgitation III: Medical Management
326
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
326